QT Medical named finalist for 2025 Octane OC High Tech Awards, recognized for its innovative wireless 12-lead ECG improving cardiac care globally.

QT Medical, Inc. has focused on making hospital-grade PCA 500 12-lead ECG System more accessible outside traditional clinical settings.

QT Medical Joins the 2025 Mayo Clinic and ASU MedTech Accelerator Cohort

QT Medical announces that it has received Health Canada’s Medical Device License (MDL) registration, marking a milestone in the company’s global expansion

QT Medical is excited to announce its selection as a Finalist for the prestigious 2024 Digital Health Hub Foundation: Digital Health Awards. QT Medical is a Finalist in the Best in Class – Kids Health category, underscoring its leadership in transforming healthcare for children.

QT Medical launches the worlds first 12-lead ECG service for home use - Xpress ECG™

QT Medical announces FDA clearance of PCA 500, a resting 12-lead electrocardiogram (ECG or EKG), for use in pediatric patients. First cleared in 2018 for professional and personal use by adults 18 years and older, PCA 500's new FDA clearance expands its indication for use to all pediatric populations, including: newborns, infants, children and adolescents.

QT Medical, Inc. (QT Medical), a medtech company focusing on electrocardiogram (ECG or EKG) technology, announces today that it raised $12 million in Series B financing. This funding will accelerate QT Medical’s market penetration, global expansion, product pipeline development, and long-term strategic planning.